MedPath

High flow oxygen therapy versus non-invasive ventilation for prevention of the need for repeat use of invasive mechanical ventilation in patients with increased blood carbon dioxide levels at the time of removal of endotracheal tube - a randomised controlled trial.

Phase 3
Conditions
Health Condition 1: J962- Acute and chronic respiratory failure
Registration Number
CTRI/2023/09/057425
Lead Sponsor
AIIMS New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Adults with hypercapnia at the time of extubation

Exclusion Criteria

1. Patients less than 18 years of age

2. Pregnant and breast-feeding women

3. Patients with do-not-resuscitate orders

4. Tracheostomised patients

5. Patients who underwent unplanned extubation (accidental extubation or self-extubation)

6. Patients with any contraindication for NIV (like orofacial/cranial trauma or surgery, orofacial malformation, excessive amount of secretions, weak cough and recent esophageal or gastric anastomosis, active emesis)

7. Patients receiving domiciliary non-invasive ventilation prior to hospitalisation

8. Refusal to consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To compare the reintubation rates within 72 hours after extubation between the two study groups. <br/ ><br>2. To compare the treatment failure rates between the two study groups.Timepoint: 1.To compare the reintubation rates within 72 hours after extubation between the two study groups. <br/ ><br>2. To compare the treatment failure rates between the two study groups.
Secondary Outcome Measures
NameTimeMethod
1.Respiratory rate at hour 1, hour 6, hour 24, hour 48 & hour 72 <br/ ><br>2.PH, paCO2, PF ratio at hour 1, hour 6, hour 24, hour 48 & hour 72 <br/ ><br>3.Reintubation rates from extubation to day 28 <br/ ><br>4.Days free of any ventilatory support from extubation to day 28 <br/ ><br>5.Treatment intolerance rates <br/ ><br>6.Nasofacial skin breakdown score (H1, 6, 24, 48, 72) <br/ ><br>7.Patient comfort score using VAS (H1, 6, 24, 48, 72) <br/ ><br>8.BORG dyspnea score (H1, 6, 24, 48, 72) <br/ ><br>9.Length of hospital and ICU stay <br/ ><br>10.ICU and in hospital mortality ratesTimepoint: Hours 1, 6, 24, 48, 72
© Copyright 2025. All Rights Reserved by MedPath